NCT01774500View on ClinicalTrials.gov

Biomarkers In Seizure To Predict Recurrence and Severe Outcomes

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2014

Conditions
SeizuresS-100b ProteinCopeptin
Trial Locations (4)

75010

Hopital Lariboisiere, Paris

75013

Groupe Hospitalier pitie-salpetriere, Paris

75020

Hopital Tenon, Paris

E1 1BB

Royal London Hospital, Barts Health NHS Trust, London

All Listed Sponsors
collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

collaborator

Barts & The London NHS Trust

OTHER

lead

Bistro Study Group

OTHER

NCT01774500 - Biomarkers In Seizure To Predict Recurrence and Severe Outcomes | Biotech Hunter | Biotech Hunter